Feng Chi Biotech Corp. (6744.TWO)
TWD 19.7
(0.0%)
TWD 19.7
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 34.83 Million TWD | -5.3% |
| 2022 | 36.78 Million TWD | -0.46% |
| 2021 | 36.95 Million TWD | -7.34% |
| 2020 | 39.88 Million TWD | 44.57% |
| 2019 | 27.58 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 6.95 Million TWD | 0.0% |
| 2024 Q1 | 6.95 Million TWD | 21.43% |
| 2023 Q4 | 5.72 Million TWD | 0.0% |
| 2023 FY | - TWD | -5.3% |
| 2023 Q3 | 5.72 Million TWD | -33.48% |
| 2023 Q2 | 8.6 Million TWD | 0.0% |
| 2023 Q1 | 8.6 Million TWD | 31.87% |
| 2022 Q4 | 6.52 Million TWD | 0.0% |
| 2022 FY | - TWD | -0.46% |
| 2022 Q3 | 6.52 Million TWD | 0.0% |
| 2021 FY | - TWD | -7.34% |
| 2020 FY | - TWD | 44.57% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 155.883% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 133.623% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 143.508% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 123.867% |
| NaviFUS Corp. | -55.79 Million TWD | 162.439% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 65.105% |
| TaiRx, Inc. | -208.64 Million TWD | 116.697% |
| Sinew Pharma Inc. | -163.63 Million TWD | 121.291% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 103.252% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 2105.642% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 115.369% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 175.335% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 91.149% |
| AP Biosciences Inc | -325.51 Million TWD | 110.702% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 96.28% |
| RBC Bioscience Corporation | 36.54 Million TWD | 4.676% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 91.965% |
| EirGenix Inc. | -664.4 Million TWD | 105.243% |
| Enimmune corporation | -228.96 Million TWD | 115.216% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 232.464% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 105.105% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 197.188% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 238.065% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 110.262% |
| TCI GENE Inc. | 25.98 Million TWD | -34.09% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 296.536% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 105.167% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 177.502% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 148.309% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 121.658% |
| Neith Corporation | -33.61 Million TWD | 203.654% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 49.615% |
| VBI | -6.97 Million TWD | 599.684% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 94.685% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 124.244% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 205.551% |
| CHO Pharma, Inc. | -277.73 Million TWD | 112.544% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 156.647% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 131.488% |
| Visgeneer Inc. | 973 Thousand TWD | -3480.473% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 81.893% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 52.86% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 309.893% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 177.869% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 130.801% |
| GlycoNex Incorporation | -126.82 Million TWD | 127.469% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 103.335% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | -19.595% |
| PharmaEngine, Inc. | 347.3 Million TWD | 89.969% |
| Intech Biopharm Corporation | -219.58 Million TWD | 115.865% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -59.734% |
| BiOptic Inc. | 65.03 Million TWD | 46.434% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 79.772% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 112.276% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -151.538% |
| OBI Pharma, Inc. | -855.08 Million TWD | 104.074% |
| Savior Lifetec Corporation | 219.6 Million TWD | 84.136% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 163.44% |
| Level Biotechnology Inc. | 98.7 Million TWD | 64.705% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 103.515% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 137.637% |
| Acepodia, Inc. | -764.51 Million TWD | 104.557% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 107.572% |